175 related articles for article (PubMed ID: 32329119)
1. Immune-related hepatitis related to checkpoint inhibitors: Clinical and prognostic factors.
Riveiro-Barciela M; Barreira-Díaz A; Vidal-González J; Muñoz-Couselo E; Martínez-Valle F; Viladomiu L; Mínguez B; Ortiz-Velez C; Castells L; Esteban R; Buti M
Liver Int; 2020 Aug; 40(8):1906-1916. PubMed ID: 32329119
[TBL] [Abstract][Full Text] [Related]
2. Characterization of liver injury induced by cancer immunotherapy using immune checkpoint inhibitors.
De Martin E; Michot JM; Papouin B; Champiat S; Mateus C; Lambotte O; Roche B; Antonini TM; Coilly A; Laghouati S; Robert C; Marabelle A; Guettier C; Samuel D
J Hepatol; 2018 Jun; 68(6):1181-1190. PubMed ID: 29427729
[TBL] [Abstract][Full Text] [Related]
3. Retreatment With Immune Checkpoint Inhibitors After a Severe Immune-Related Hepatitis: Results From a Prospective Multicenter Study.
Riveiro-Barciela M; Barreira-Díaz A; Callejo-Pérez A; Muñoz-Couselo E; Díaz-Mejía N; Díaz-González Á; Londoño MC; Salcedo MT; Buti M
Clin Gastroenterol Hepatol; 2023 Mar; 21(3):732-740. PubMed ID: 35487453
[TBL] [Abstract][Full Text] [Related]
4. Severe immune-related hepatitis induced by immune checkpoint inhibitors: Clinical features and management proposal.
Gauci ML; Baroudjian B; Bédérède U; Zeboulon C; Delyon J; Allayous C; Madelaine I; Eftekhari P; Resche-Rigon M; Poté N; Paradis V; Durand F; Lebbé C; Roux O; Bouattour M;
Clin Res Hepatol Gastroenterol; 2021 Mar; 45(2):101491. PubMed ID: 32773362
[TBL] [Abstract][Full Text] [Related]
5. Dynamic cytokines signature predicts survival outcome from severe Immune-related hepatitis with PD-1/PD-L1 blockade in lung cancer.
Zeng L; Zhou Y; Xu Q; Huang Z; Song L; Wang Z; Deng L; Wu Y; Liang Y; Liu Z; Gao X; Yi X; He Q; Xia X; Yang H; Zhang X; Yan H; Qin H; Lin S; Yang N; Zhang Y
Lung Cancer; 2023 Oct; 184():107350. PubMed ID: 37659241
[TBL] [Abstract][Full Text] [Related]
6. Clinical features of autoimmune hepatitis with acute presentation: a Japanese nationwide survey.
Joshita S; Yoshizawa K; Umemura T; Ohira H; Takahashi A; Harada K; Hiep NC; Tsuneyama K; Kage M; Nakano M; Kang JH; Koike K; Zeniya M; Yasunaka T; Takaki A; Torimura T; Abe M; Yokosuka O; Tanaka A; Takikawa H;
J Gastroenterol; 2018 Sep; 53(9):1079-1088. PubMed ID: 29476251
[TBL] [Abstract][Full Text] [Related]
7. Defining characteristics and long-term prognosis of drug-induced autoimmune-like hepatitis: A retrospective cohort study.
Chung Y; Morrison M; Zen Y; Heneghan MA
United European Gastroenterol J; 2024 Feb; 12(1):66-75. PubMed ID: 38041550
[TBL] [Abstract][Full Text] [Related]
8. [Clinical and pathological characteristics and outcome of 46 children with autoimmune hepatitis].
Cao LL; Zhang M; Zhu SS; Dong Y; Xu ZQ; Chen DW; Wang LM; Wang FC; Gan Y; Yan JG; Wang P; Li AQ
Zhonghua Er Ke Za Zhi; 2019 Jan; 57(1):40-45. PubMed ID: 30630230
[No Abstract] [Full Text] [Related]
9. Characteristics of autoimmune hepatitis in Taiwan: the 11 years' experiences of a medical center.
Huang HC; Huang YS; Wu JC; Tsay SH; Huo TI; Wang YJ; Lo JC; Chen CY; Li CP; Chang FY; Lee SD
Zhonghua Yi Xue Za Zhi (Taipei); 2002 Dec; 65(12):563-9. PubMed ID: 12636201
[TBL] [Abstract][Full Text] [Related]
10. Prognosis of acute severe autoimmune hepatitis (AS-AIH): the role of corticosteroids in modifying outcome.
Yeoman AD; Westbrook RH; Zen Y; Bernal W; Al-Chalabi T; Wendon JA; O'Grady JG; Heneghan MA
J Hepatol; 2014 Oct; 61(4):876-82. PubMed ID: 24842305
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of corticosteroids for the treatment of severe and fulminant forms of autoimmune hepatitis.
Ichai P; Duclos-Vallée JC; Guettier C; Hamida SB; Antonini T; Delvart V; Saliba F; Azoulay D; Castaing D; Samuel D
Liver Transpl; 2007 Jul; 13(7):996-1003. PubMed ID: 17370335
[TBL] [Abstract][Full Text] [Related]
12. Immune-Mediated Hepatitis During Immune Checkpoint Inhibitor cancer Immunotherapy: Lessons From Autoimmune Hepatitis and Liver Immunology.
Hercun J; Vincent C; Bilodeau M; Lapierre P
Front Immunol; 2022; 13():907591. PubMed ID: 35844534
[TBL] [Abstract][Full Text] [Related]
13. Clinical and prognostic implications of acute onset of Autoimmune Hepatitis: An Italian multicentre study.
Muratori P; Carbone M; Stangos G; Perini L; Lalanne C; Ronca V; Cazzagon N; Bianchi G; Lenzi M; Floreani A; Invernizzi P; Muratori L
Dig Liver Dis; 2018 Jul; 50(7):698-702. PubMed ID: 29567415
[TBL] [Abstract][Full Text] [Related]
14. Hepatotoxicity of immune checkpoint inhibitors: a histology study of seven cases in comparison with autoimmune hepatitis and idiosyncratic drug-induced liver injury.
Zen Y; Yeh MM
Mod Pathol; 2018 Jun; 31(6):965-973. PubMed ID: 29403081
[TBL] [Abstract][Full Text] [Related]
15. Clinical and Pathological Features of Immune Checkpoint Inhibitor-induced Liver Injury in Comparison with Drug-induced Liver Injury and Autoimmune Hepatitis.
Sunago K; Abe M; Yoshida O; Watanabe T; Nakamura Y; Imai Y; Koizumi Y; Hirooka M; Tokumoto Y; Hiasa Y
J Gastrointestin Liver Dis; 2023 Dec; 32(4):488-496. PubMed ID: 38147620
[TBL] [Abstract][Full Text] [Related]
16. Acute onset of autoimmune hepatitis in children and adolescents.
Smolka V; Tkachyk O; Ehrmann J; Karaskova E; Zapalka M; Volejnikova J
Hepatobiliary Pancreat Dis Int; 2020 Feb; 19(1):17-21. PubMed ID: 31474443
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological Features of Autoimmune Hepatitis with IgG4-Positive Plasma Cell Infiltration.
Arase Y; Matsumoto K; Anzai K; Tsuruya K; Sugiyama S; Yoshihara S; Hirose S; Uojima H; Hidaka H; Nakazawa T; Deguchi R; Kojima S; Takashimizu S; Shiraishi K; Shirai T; Kagawa T
Dig Dis; 2021; 39(3):225-233. PubMed ID: 32731217
[TBL] [Abstract][Full Text] [Related]
18. Immune checkpoint inhibitor-related cholangiopathy: Novel clinicopathological description of a multi-centre cohort.
Berry P; Kotha S; Zen Y; Papa S; El Menabawey T; Webster G; Joshi D; Heneghan M
Liver Int; 2023 Jan; 43(1):147-154. PubMed ID: 35704341
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics and treatment outcomes of acute severe autoimmune hepatitis.
Zheng L; Liu Y; Shang Y; Han Z; Han Y
BMC Gastroenterol; 2021 Mar; 21(1):93. PubMed ID: 33648445
[TBL] [Abstract][Full Text] [Related]
20. PD-1/PD-L1 inhibitors associated hypophysitis: An analysis from the FAERS database and case reports.
Chen S; Ouyang L; Li L; Xiao Y; Wang S
Drug Discov Ther; 2024 Mar; 18(1):34-43. PubMed ID: 38382932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
